As bioinformatic tools now offer more complex analytical approaches, it is possible that unique receptor splice variants, such as TrkB.T1, may prove to be crucial for understanding glioma biology, and oncogenic signaling in general. This evidence concerns the gene NTRK2 and central nervous system cancer.